Phenobarbital and 3-methylcholanthrene treatment alters phase I and II enzymes and the sensitivity of the rat colon to the carcinogenic activity of azoxymethane

Food and Chemical Toxicology

Volumn 35, Issue 8, 1997, Pages 789-798

  Baijal, P K ^a   Fitzpatrick, D W ^a   Bird, R P ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

3 methylcholanthrene; Aberrant crypt foci; Phase I and II enzymes; Phenobarbital

Indexed keywords

AZOXYMETHANE; DRUG METABOLIZING ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RISK; CARCINOGENIC ACTIVITY; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; ENZYME INDUCTION; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; AZOXYMETHANE; BIOTRANSFORMATION; CARCINOGENS; COLON; ENZYME INDUCTION; GABA MODULATORS; GLUCOSYLTRANSFERASES; GLUTATHIONE TRANSFERASE; INTESTINAL MUCOSA; MALE; METHYLCHOLANTHRENE; NADH DEHYDROGENASE; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0030773355     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(97)00059-8     Document Type: Article

References (34)

1. American Institute of Nutrition (AIN) (1980) Second report of the Ad Hoc Committee on standards for Nutritional Studies. Journal of Nutrition 110, 1726-1730.
2. Baijal P. K. and Fitzpatrick D. W. (1996) Effect of dietary protein on hepatic and extrahepatic phase I and II drug metabolizing enzymes. Toxicology Letters 89, 99-106.
3. Bird R. P. (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Letters 37, 147-151.
4. Bird R. P. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Letters 93, 55-71.
5. Bock K. W., Josting D., Lilienblum W. and Pfeil H. (1979) Purification of rat liver microsomal UDP-glucuronyltransferase: separation of two enzyme forms inducible by 3-methylcholanthrene or phenobarbital. European Journal of Biochemistry 98, 19-26.
6. Burchell B., Coughtrie M. W. H. and Jansen P. L. M. (1994) Function and regulation of UDP-glucuronyltransferase genes in health and liver disease: report of the seventh international workshop on glucuronidation. Hepatology 20, 1622-1630.
7. Correa P. (1981) Epidemiological correlation between diet and cancer frequency. Cancer Research 41, 3685-3689.
8. de Waziers I., Cugnenc P. H., Berger A. , Leroux J. P. and Beaune P. H. (1991) Drug metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples. Carcinogenesis 12, 905-909.
9. Fang W. F. and Strobel H. W. (1978) The drug and carcinogen metabolism system of rat colon microsomes. Archives of Biochemistry and Biophysics 186, 4515-4521.
10. Farber E. and Rubin H. (1991) Cellular adaptation in the origin and development of cancer. Cancer Research 51, 2751-2761.
11. Guengerich F. P. (1994) Analysis and characterization of enzymes. In Principle and Methods of Toxicology. Edited by A. W. Hayes. 3rd Ed. pp. 1259-1314. Raven Press, New York.
12. Habig W. H., Pabst M. J. and Jakoby W. B. (1974) Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 249, 7130-7139.
13. Hathcock J. N. (1982) Nutritional toxicology: definition and scope. In Nutritional Toxicology. Vol. 1. Edited by J.N. Hathcock. pp. 1-16. Academic Press, New York.
14. Hoensch H. P. and Hartman F. (1981) The intestinal enzymatic biotransformation system: potential role in protection from colon cancer. Hepatogastroenterololgy 28, 221-228.
15. Klassen C. D. and Eaton D. L. (1991) Principles of toxicology. In Cassarett and Doull's Toxicology. The Basic Science of Poisons. Edited by M. O. Amdur, J. Doull and C. D. Klassen. 4th Ed. pp. 12-49. Pergamon, New York.
16. Kune S., Kune G. A. and Watson L. F. (1987) Case-control study of dietary etiological factors: the Melbourne colorectal cancer study. Nutrition and Cancer 9, 21-42.
17. Lafave L. and Bird R. P. (1994) Effect of dietary fat on colonic protein kinase C and induction of aberrant crypt foci. Lipids 29, 693-700.
18. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurements with the Folin phenol reagent. Journal of Biological Chemistry 193, 265-275.
19. McKay J. A., Murray G. I., Weaver R. J., Ewen S. W. B., Melvin W. T. and Burke M. D. (1993) Xenobiotic metabolizing enzyme expression in colonic neoplasia. Gut 34, 1234-1239.
20. McLellan E. A. and Bird R. P. (1988) Aberrant crypts: Potential preneoplastic lesions in the murine colon. Cancer Research 48, 6187-6192.
21. Magnusson B. A., Carr I. and Bird R. P. (1993) Ability of aberrant crypt foci to predict colonic tumour incidence in rats fed cholic acid. Cancer Research 53, 4499-4504.
22. Massaad L., de Waziers I., Ribrag V., Janot F., Beaune P. H., Morizet J., Gouyette A. and Chabot G. G. (1993) Comparison of mouse and human colon tumours with regard to phase I and phase II drug-metabolizing enzyme systems. Cancer Research 52, 6567-6575.
23. Moorghen M., Cairns J., Forrester L. M., Hayes J. D., Hall A., Cattan A. R., Wolf C. R. and Harris A. L. (1991) Enhanced expression of glutathione S-transferases in colorectal carcinoma compared to non neoplastic mucosa. Carcinogenesis 12, 13-17.
24. Paglia D. E. and Valentine W. N. (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine 70, 158-169.
25. Pandey A., Hassen A. M., Benedict D. R. and Fitzpatrick D. W. (1990) Effect of UDP-glucuronyltransferase induction on zearalenone metabolism. Toxicology Letters 51, 203-211.
26. Pretlow T. P., Barrow B. J., Ashton W. S., O'Riordan M. A., Pretlow T. G., Jurcisek J. A. and Stellato T. A. (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Research 51, 1564-1567.
27. Pretlow T. P., O'Riordan M. A., Somich G. A., Amini S. B. and Pretlow T. G. (1992) Aberrant crypts correlate with tumour incidence in F344 rats treated with azoxy-methane and phytate. Carcinogenesis 13, 1509-1512.
28. Rodriguez A. D. and Plough R. A. (1991) Induction of phase I and II enzymes and measurements of catalytic activities. In Methods in Enzymology. Vol. 206. Edited by M. R. Waterman and E. F. Johnson. pp. 423-431. Academic Press, New York.
29. Roomi M. W., Ho R. K., Sarma D. S. R. and Farber E. A. (1985) A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat. Cancer Research 45, 564-571.
30. Rosenberg D. W. (1991) Tissue specific induction of the carcinogen inducible cytochrome P450 isoform, P450IA1, in colonic epithelium. Archives of Biochemistry and Biophysics 284, 223-226.
31. Sipes G. and Gandolfi A. J. (1991) Biotransformation of toxicants. In Cassarett and Doull's Toxicology. The Basic Science of Poisons. Edited by M. O. Amdur, J. Doull and C. D. Klassen. 4th Ed. pp. 88-126. Pergamon, New York.
32. Steinmetz K. A. and Potter J. D. (1993) Food-group consumption and colon cancer in the Adelaide case control study. I Vegetables and fruit. International Journal of Cancer 53, 711-719.
33. Stralka D. J. and Strobel H. W. (1989) Cytochrome P450 activity and distribution in the human colon mucosa. Cancer 64, 2111-2116.
34. Testai E., Keizer J., Pacifici G. M. and Vittozzi L. (1991) Chloroform bioactivation by microsomes from colonic and ileal mucosa of rat and man. Toxicology Letters 57, 19-27.